I.D. Kaplan

Beth Israel Deaconess Medical Center

Papers

6

Total Citations

82

H-Index

5

About

I.D. Kaplan is a radiation oncologist whose research has made meaningful contributions to the field of stereotactic body radiation therapy (SBRT) and radiosurgery, with a particular focus on genitourinary cancers. Kaplan's work has helped establish SBRT as a viable treatment modality for prostate cancer, spanning both low- and intermediate-risk disease, with key investigations into patient-reported outcomes, toxicity profiles, and long-term efficacy. His most-cited work — a 2013 phase 1 dose-escalation study exploring robotic radiosurgery for inoperable renal cell carcinoma — has garnered 43 citations and represents a pioneering effort to expand minimally invasive radiation options to kidney cancer patients previously lacking surgical alternatives. Contributing to multicenter and international trials, including the PACE study, Kaplan has demonstrated a commitment to rigorous comparative evidence and patient-centered research. His 2016 five-year outcomes study from a multicenter SBRT prostate cancer trial further solidified his role in shaping treatment standards. More recently, his work examining de-intensification strategies for intermediate-risk prostate cancer reflects an evolving focus on optimizing — and potentially reducing — treatment burden without compromising outcomes.

Research Focus

Key Achievements

5
H-Index
6
Papers
82
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
A Phase 1 Dose-Escalation Study of Robotic Radiosurgery in Inoperable Primary Renal Cell Carcinoma
43 citations · 2013
📈 Most Prolific Year: 2013 (3 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: Beth Israel Deaconess Medical Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago